TY - JOUR
T1 - Potential missed opportunities for antenatal corticosteroid exposure and outcomes among periviable births
T2 - Observational cohort study
AU - for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network
AU - Travers, Colm P.
AU - Hansen, Nellie I.
AU - Das, Abhik
AU - Rysavy, Matthew A.
AU - Bell, Edward F.
AU - Ambalavanan, Namasivayam
AU - Peralta-Carcelen, Myriam
AU - Tita, Alan T.
AU - Van Meurs, Krisa P.
AU - Carlo, Waldemar A.
AU - Polin, Richard A.
AU - Caplan, Michael S.
AU - Laptook, Abbott R.
AU - Keszler, Martin
AU - Hensman, Angelita M.
AU - Knoll, Andrea M.
AU - Little, Emilee
AU - Vieira, Elisa
AU - Basso, Kristin M.
AU - Keller, Jennifer A.
AU - St Pierre, Lucille
AU - Walsh, Michele C.
AU - Hibbs, Anna Maria
AU - Fanaroff, Avroy A.
AU - Newman, Nancy S.
AU - Payne, Allison H.
AU - Truog, William E.
AU - Pallotto, Eugenia K.
AU - Kilbride, Howard W.
AU - Gauldin, Cheri
AU - Holmes, Anne
AU - Johnson, Kathy
AU - Knutson, Allison
AU - Parimi, Prabhu S.
AU - Gaetano, Lisa
AU - Merhar, Stephanie L.
AU - Poindexter, Brenda B.
AU - Schibler, Kurt
AU - Donovan, Edward F.
AU - Grisby, Cathy
AU - Alexander, Barbara
AU - Bridges, Kate
AU - Fischer, Estelle E.
AU - Mincey, Holly L.
AU - Hessling, Jody
AU - Jackson, Lenora
AU - Sanchez, Pablo J.
AU - Wyckoff, Myra H.
AU - Brion, Luc P.
AU - Rosenfeld, Charles R.
N1 - Publisher Copyright:
© 2022 John Wiley & Sons Ltd.
PY - 2022/11
Y1 - 2022/11
N2 - Objective: To test the hypothesis that potential missed opportunities for antenatal corticosteroids increase as gestational age decreases and are associated with adverse outcomes. Design: Observational cohort study. Setting: Twenty-four US centers in the Neonatal Research Network. Population: Actively treated infants at 22–25 weeks of gestation and with birthweight 401–1000 g, without major birth defects, born 2006–18. Methods: Potential missed opportunity was defined as no antenatal corticosteroids but did have prenatal antibiotics, and/or magnesium sulphate, and/or prolonged rupture of membranes. Poisson regression models adjusted for baseline characteristics. Main outcome measures: Antenatal corticosteroid exposure, mortality and severe intracranial haemorrhage or periventricular leucomalacia. Results: A total of 6966 (87.5%) infants were exposed to antenatal corticosteroids, 454 (5.7%) had no exposure but potential missed opportunities for antenatal corticosteroid exposure, and 537 (6.7%) had no exposure and no evidence of potential missed opportunities. Compared with infants born at 25 weeks, potential missed opportunities for antenatal corticosteroid exposure were more likely at 22 weeks (adjusted relative risk [aRR] 11.06, 95% confidence interval [CI] 7.52–16.27) and 23 weeks (aRR 3.24, 95% CI 2.44–4.29) but did not differ at 24 weeks (aRR 1.08, 95% CI 0.82–1.42). Potential missed opportunities for antenatal corticosteroids decreased over time at 22–23 weeks of gestation. Antenatal-corticosteroid-exposed infants had lower risk of death (31.0% versus 54.8%; aRR 0.77, 95% CI 0.70–0.84) and survivors had lower risk of severe brain injury (25.0% versus 44.5%; aRR 0.64, 95% CI 0.55–0.73) compared with infants with potential missed opportunities. Conclusion: Potential missed opportunities for antenatal corticosteroid exposure increased with decreasing gestational age and were associated with higher rates of death and severe brain injury among actively treated periviable births.
AB - Objective: To test the hypothesis that potential missed opportunities for antenatal corticosteroids increase as gestational age decreases and are associated with adverse outcomes. Design: Observational cohort study. Setting: Twenty-four US centers in the Neonatal Research Network. Population: Actively treated infants at 22–25 weeks of gestation and with birthweight 401–1000 g, without major birth defects, born 2006–18. Methods: Potential missed opportunity was defined as no antenatal corticosteroids but did have prenatal antibiotics, and/or magnesium sulphate, and/or prolonged rupture of membranes. Poisson regression models adjusted for baseline characteristics. Main outcome measures: Antenatal corticosteroid exposure, mortality and severe intracranial haemorrhage or periventricular leucomalacia. Results: A total of 6966 (87.5%) infants were exposed to antenatal corticosteroids, 454 (5.7%) had no exposure but potential missed opportunities for antenatal corticosteroid exposure, and 537 (6.7%) had no exposure and no evidence of potential missed opportunities. Compared with infants born at 25 weeks, potential missed opportunities for antenatal corticosteroid exposure were more likely at 22 weeks (adjusted relative risk [aRR] 11.06, 95% confidence interval [CI] 7.52–16.27) and 23 weeks (aRR 3.24, 95% CI 2.44–4.29) but did not differ at 24 weeks (aRR 1.08, 95% CI 0.82–1.42). Potential missed opportunities for antenatal corticosteroids decreased over time at 22–23 weeks of gestation. Antenatal-corticosteroid-exposed infants had lower risk of death (31.0% versus 54.8%; aRR 0.77, 95% CI 0.70–0.84) and survivors had lower risk of severe brain injury (25.0% versus 44.5%; aRR 0.64, 95% CI 0.55–0.73) compared with infants with potential missed opportunities. Conclusion: Potential missed opportunities for antenatal corticosteroid exposure increased with decreasing gestational age and were associated with higher rates of death and severe brain injury among actively treated periviable births.
KW - antenatal births corticosteroids
KW - extremely preterm infant
KW - infant
KW - intracranial haemorrhage
KW - intraventricular haemorrhage
KW - missed opportunities
KW - mortality
KW - newborn
KW - periviable
UR - http://www.scopus.com/inward/record.url?scp=85131402002&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85131402002&partnerID=8YFLogxK
U2 - 10.1111/1471-0528.17230
DO - 10.1111/1471-0528.17230
M3 - Article
C2 - 35611472
AN - SCOPUS:85131402002
SN - 1470-0328
VL - 129
SP - 2039
EP - 2051
JO - BJOG: An International Journal of Obstetrics and Gynaecology
JF - BJOG: An International Journal of Obstetrics and Gynaecology
IS - 12
ER -